Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The ...
The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...
The price target boosts come after LLY stock rose 30% during November amid a strong rally in the shares. The bull run comes after Eli Lilly reported strong third-quarter financial results and struck a ...
Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 ...
Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook ...
Pfizer ( PFE +0.26%) and Eli Lilly ( LLY +1.80%) are two prominent names in healthcare that have focused on innovation and ...
On December 16, Daiwa analyst Narumi Nakagiri upgraded Eli Lilly and Company (NYSE:LLY) to Buy from Neutral and set a $1,230 ...
Why Eli Lilly Stock Keeps Pushing Higher Eli Lilly (LLY) has been grinding higher again, with shares up roughly 2% over the ...
J. L. Bainbridge & Co. bought 61,258 shares of Eli Lilly and Company for an estimated $45.6 million in the third quarter. Post-transaction, the wealth advisory reported owning 61,782 shares of Eli ...
Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...
Eli Lilly just agreed to lower the price of its blockbuster GLP-1 weight loss drug. More than half of the company's revenue comes from just two weight loss drugs. Wall Street may be pricing in too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback